Table 4.
Univariate analysis of clinical and demographic variables of interest
| Continence at 6 Months | Continence at 12 Months | |||
|---|---|---|---|---|
| OR (95% CI) | p-value | OR (95% CI) | p-value | |
| Age* | - | <0.0001 | - | <0.0001 |
| BMI | 0.97 (0.95, 0.99) | 0.01 | 0.98 (0.96, 1.01) | 0.1 |
| ASA Score (III/IV vs. I/II) | 0.71 (0.57, 0.87) | 0.001 | 0.63 (0.49, 0.80) | 0.0002 |
| PSA | 0.99 (0.97, 1.00) | 0.1 | 1.00 (0.99, 1.02) | 0.9 |
| Clinical Stage | 0.06 | 0.02 | ||
| ≤T1C | Ref. | Ref. | Ref. | Ref. |
| T2A | 1.01 (0.81, 1.27) | - | 1.15 (0.87, 1.52) | 0.3 |
| ≥T2B | 0.76 (0.61, 0.95) | - | 0.74 (0.57, 0.95) | 0.018 |
| Clinical Gleason Score | 0.1 | 0.2 | ||
| ≤6 | Ref. | Ref. | Ref. | Ref. |
| 7 | 0.84 (0.71, 1.00) | - | 0.90 (0.73, 1.10) | - |
| ≥8 | 0.82 (0.60, 1.12) | - | 0.72 (0.50, 1.04) | - |
| Year of Surgery (>2005 vs. ≤2005) | 0.83 (0.70, 0.99) | 0.04 | 1.21 (0.99, 1.48) | 0.07 |
| History of TURP | 0.37 (0.19, 0.72) | 0.003 | 0.27 (0.14, 0.52) | 0.0001 |
Age was modeled using non-linear terms, so the OR and 95% CI are not provided.